GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Cash Ratio

Fractyl Health (Fractyl Health) Cash Ratio : 2.97 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Fractyl Health's Cash Ratio for the quarter that ended in Dec. 2023 was 2.97.

Fractyl Health has a Cash Ratio of 2.97. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Fractyl Health's Cash Ratio or its related term are showing as below:

GUTS' s Cash Ratio Range Over the Past 10 Years
Min: 1.53   Med: 2.97   Max: 6.74
Current: 2.97

During the past 5 years, Fractyl Health's highest Cash Ratio was 6.74. The lowest was 1.53. And the median was 2.97.

GUTS's Cash Ratio is ranked better than
50.92% of 1526 companies
in the Biotechnology industry
Industry Median: 2.85 vs GUTS: 2.97

Fractyl Health Cash Ratio Historical Data

The historical data trend for Fractyl Health's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Cash Ratio Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
1.53 2.67 4.04 6.74 2.97

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.74 3.74 5.30 2.97

Competitive Comparison of Fractyl Health's Cash Ratio

For the Biotechnology subindustry, Fractyl Health's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Cash Ratio falls into.



Fractyl Health Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Fractyl Health's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=33.209/11.188
=2.97

Fractyl Health's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=33.209/11.188
=2.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fractyl Health  (NAS:GUTS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Fractyl Health Cash Ratio Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health (Fractyl Health) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.